Spectrum and burden of dermatophytes in children

https://doi.org/10.1016/S0163-4453(17)30192-5Get rights and content

Summary

Tinea capitis is the most important superficial fungal condition in children. It is often unrecognised but the presence of alopecia, scale and lymphadenopathy, especially in inner-city children should prompt investigation. An understanding of changing epidemiology and prevalence of causative organisms is important in deciding appropriate therapy. The use of diagnostic aids including dermoscopy is increasing and is reported to be helpful in identifying subtle signs. Trichophyton tonsurans accounts for the majority of cases in the UK and terbinafine is increasingly advocated as a safe and effective therapy. Exclusion from school is unnecessary provided the child is receiving appropriate systemic and topical therapy, but family members should be screened and carriers should receive treatment. Steroids and surgical treatments should be avoided. Treatment failure is common and may be multifactorial. Mycological cure after completing treatment should be sought and therefore follow up is necessary for Tinea capitis cases. Development of molecular diagnostic methods may improve our ability to diagnose Tinea capitis accurately and quickly in the future. Emerging new dermatophytoses affecting other anatomical sites are discussed which, although not common in the UK, may be seen due to increasing travel worldwide.

References (0)

Cited by (36)

  • Case Report: Diagnosing Dermatophytoses in Children

    2024, Journal of Pediatric Health Care
  • Determination of terbinafine in healthy Chinese human plasma using a simple and fast LC-MS/MS method and its application to a bioequivalence study

    2022, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
    Citation Excerpt :

    Terbinafine is a unique antifungal drug among allylamines, with both topical and oral routes of administration. It has a broad-spectrum antifungal activity against filamentous fungi, biphasic fungi, and yeasts [5], and its antifungal activity against dermatophytes is particularly prominent [6]. Terbinafine is the current mainstream drug for the clinical treatment of superficial fungal infections of the skin; especially, it is the first-line treatment for dermatophyte infections [7].

  • Prevention and control of pediatric tinea capitis

    2023, Chinese Journal of Epidemiology
View all citing articles on Scopus
View full text